Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ahmed El-Tahtawy


Ahmed El-Tahtawy

Pfizer Inc, USA

Biography

Ahmed has completed his pharmacy degree and his PhD more than 20 years ago from USC University. He had a postdoctoralfellowship from FDA before jioing as a clinical Pharmacology reviewer.. He is now a director of Clinical Pharmacology in Pfizer, where he Integrate advanced analysis in late phase drug development in order to “fill the gaps” not addressed directly by traditional confirmatory clinical trials. The implementation of these inferential methods helped evaluate benefit/risk in special populations (Pediatrics, Elderly, patient subgroups, new indication, etc...). These inferential methods played a major role in the process of evidence synthesis, providing a strong basis for decision making.

Abstract

Abstract : Developing Useful Prognostic Tools for Risk Assessment: Predictors of Mortality in Catheter-Related Bloodstream Infections